Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study

Abstract

A1C reduction was no different between the two groups. Subjects in the CG group had increased hypoglycemia AUC and number of events during blinded CGM use; however, there was no increase in hypoglycemia AUC or number of events in the SG group. Subjects with greater sensor utilization showed a greater improvement in A1C levels.